Medway Maritime Hospital is a general hospital in Gillingham, England within the NHS South East Coast. It is run by Medway NHS Foundation Trust. It is Kent's largest and busiest hospital, dealing with around 400,000 patients annually.

There are 588 beds in Medway Maritime Hospital.

During the past decade, Medway Maritime Hospital conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 6 clinical trials were completed, i.e. on average, 13.6% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 4 clinical trials were completed. i.e. 36.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medway Maritime Hospital" #1 sponsor was "Medway NHS Foundation Trust" with 7 trials, followed by "University College, London" with 5 trials sponsored, "Royal Marsden NHS Foundation Trust" with 3 trials sponsored, "Thayyil, Sudhin" with 3 trials sponsored and "University Hospital Southampton NHS Foundation Trust" with 3 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medway Maritime Hospital" #1 collaborator was "Cancer Research UK" with 6 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 3 trials as a collaborator, "King's College London" with 2 trials as a collaborator, "Medway NHS Foundation Trust" with 2 trials as a collaborator and "NHS Lothian" with 2 trials as a collaborator. Other collaborators include 57 different institutions and companies that were collaborators in the rest 65 trials.

According to Clinical.Site data, the most researched conditions in "Medway Maritime Hospital" are "Lymphoma" (4 trials), "Breast Cancer" (3 trials), "Critical Illness" (3 trials), "Leukemia" (3 trials) and "Myelodysplastic Syndromes" (3 trials). Many other conditions were trialed in "Medway Maritime Hospital" in a lesser frequency.

Most popular intervention types in "Medway Maritime Hospital" are "Drug" (31 trials), "Other" (17 trials), "Procedure" (14 trials), "Biological" (10 trials) and "Device" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Cyclophosphamide" (3 trials), "Rituximab" (3 trials), "cyclophosphamide" (3 trials) and "mitoxantrone hydrochloride" (3 trials). Other intervention names were less common.

The vast majority of trials in "Medway Maritime Hospital" are 53 trials for "All" genders, 11 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Medway Maritime Hospital". undefined are not yet recruiting, 12 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Medway Maritime Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Medway Maritime Hospital, 0 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 16 trials that are defined as “Not Applicable".